Global Volatile Inhalational Anesthetics Market Growth 2026-2032
The global Volatile Inhalational Anesthetics market size is predicted to grow from US$ 1032 million in 2025 to US$ 1356 million in 2032; it is expected to grow at a CAGR of 4.0% from 2026 to 2032.
Volatile inhalational anesthetics are halogenated organic liquids that readily vaporize and are delivered as a controlled concentration in a patient’s inspired gases through an anesthesia machine and vaporizer to produce general anesthesia. After inhalation, they diffuse from the lungs into the bloodstream and then into the brain, where they cause unconsciousness, amnesia, and varying degrees of immobility and analgesia; anesthesiologists adjust their effect quickly by changing the inspired concentration and by managing ventilation, making them useful for induction (in selected patients) and especially for maintenance of anesthesia during surgery. Common modern agents include sevoflurane, desflurane, and isoflurane, and their clinical use is balanced against side effects such as dose-dependent drops in blood pressure, respiratory depression, postoperative nausea, rare malignant hyperthermia susceptibility, and increasing attention to occupational exposure control and their greenhouse-gas footprint. The product has an average price of $200-350 per kilogram and a production volume of approximately 4,000 tons per year.
Upstream for volatile inhalational anesthetics begins with basic petrochemical feedstocks that are converted into highly fluorinated/halogenated intermediates using specialty reagents (notably fluorinating and chlorinating agents), catalysts, and tightly controlled reaction and purification steps, because these products must meet very high purity and stability requirements under pharmaceutical GMP; manufacturers then distill and dry the anesthetic to specification, perform rigorous QC (impurities, water content, identity), and fill it into dedicated, moisture-tight bottles/canisters with compliant labeling and cold-chain-free but controlled logistics. Downstream, finished product moves through pharma wholesalers and hospital procurement channels to operating rooms and ambulatory surgery centers, where it is used with anesthesia machines and calibrated vaporizers (plus carrier gases) and supported by consumables and infrastructure such as breathing circuits, CO? absorbents, and waste-gas scavenging systems; used anesthetic largely leaves the patient via exhalation and is routed into scavenging/disposal pathways (increasingly with capture/destruction or monitoring in some facilities), while ongoing demand is driven by surgical volumes, formulary choices, and workplace exposure and environmental management practices.
United States market for Volatile Inhalational Anesthetics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Volatile Inhalational Anesthetics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Volatile Inhalational Anesthetics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Volatile Inhalational Anesthetics players cover Baxter, AbbVie, Piramal Critical Care, Fresenius Kabi, Halocarbon, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Volatile Inhalational Anesthetics Industry Forecast” looks at past sales and reviews total world Volatile Inhalational Anesthetics sales in 2025, providing a comprehensive analysis by region and market sector of projected Volatile Inhalational Anesthetics sales for 2026 through 2032. With Volatile Inhalational Anesthetics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Volatile Inhalational Anesthetics industry.
This Insight Report provides a comprehensive analysis of the global Volatile Inhalational Anesthetics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Volatile Inhalational Anesthetics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Volatile Inhalational Anesthetics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Volatile Inhalational Anesthetics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Volatile Inhalational Anesthetics.
This report presents a comprehensive overview, market shares, and growth opportunities of Volatile Inhalational Anesthetics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Volatile Inhalational Anesthetics market?
What factors are driving Volatile Inhalational Anesthetics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Volatile Inhalational Anesthetics market opportunities vary by end market size?
How does Volatile Inhalational Anesthetics break out by Type, by Application?
Volatile inhalational anesthetics are halogenated organic liquids that readily vaporize and are delivered as a controlled concentration in a patient’s inspired gases through an anesthesia machine and vaporizer to produce general anesthesia. After inhalation, they diffuse from the lungs into the bloodstream and then into the brain, where they cause unconsciousness, amnesia, and varying degrees of immobility and analgesia; anesthesiologists adjust their effect quickly by changing the inspired concentration and by managing ventilation, making them useful for induction (in selected patients) and especially for maintenance of anesthesia during surgery. Common modern agents include sevoflurane, desflurane, and isoflurane, and their clinical use is balanced against side effects such as dose-dependent drops in blood pressure, respiratory depression, postoperative nausea, rare malignant hyperthermia susceptibility, and increasing attention to occupational exposure control and their greenhouse-gas footprint. The product has an average price of $200-350 per kilogram and a production volume of approximately 4,000 tons per year.
Upstream for volatile inhalational anesthetics begins with basic petrochemical feedstocks that are converted into highly fluorinated/halogenated intermediates using specialty reagents (notably fluorinating and chlorinating agents), catalysts, and tightly controlled reaction and purification steps, because these products must meet very high purity and stability requirements under pharmaceutical GMP; manufacturers then distill and dry the anesthetic to specification, perform rigorous QC (impurities, water content, identity), and fill it into dedicated, moisture-tight bottles/canisters with compliant labeling and cold-chain-free but controlled logistics. Downstream, finished product moves through pharma wholesalers and hospital procurement channels to operating rooms and ambulatory surgery centers, where it is used with anesthesia machines and calibrated vaporizers (plus carrier gases) and supported by consumables and infrastructure such as breathing circuits, CO? absorbents, and waste-gas scavenging systems; used anesthetic largely leaves the patient via exhalation and is routed into scavenging/disposal pathways (increasingly with capture/destruction or monitoring in some facilities), while ongoing demand is driven by surgical volumes, formulary choices, and workplace exposure and environmental management practices.
United States market for Volatile Inhalational Anesthetics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Volatile Inhalational Anesthetics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Volatile Inhalational Anesthetics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Volatile Inhalational Anesthetics players cover Baxter, AbbVie, Piramal Critical Care, Fresenius Kabi, Halocarbon, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Volatile Inhalational Anesthetics Industry Forecast” looks at past sales and reviews total world Volatile Inhalational Anesthetics sales in 2025, providing a comprehensive analysis by region and market sector of projected Volatile Inhalational Anesthetics sales for 2026 through 2032. With Volatile Inhalational Anesthetics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Volatile Inhalational Anesthetics industry.
This Insight Report provides a comprehensive analysis of the global Volatile Inhalational Anesthetics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Volatile Inhalational Anesthetics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Volatile Inhalational Anesthetics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Volatile Inhalational Anesthetics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Volatile Inhalational Anesthetics.
This report presents a comprehensive overview, market shares, and growth opportunities of Volatile Inhalational Anesthetics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Heptafluoroane
- Desflurane
- Isoflurane
- Others
- Below 3%
- Above 3%
- Human Use
- Animal Use
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Baxter
- AbbVie
- Piramal Critical Care
- Fresenius Kabi
- Halocarbon
- Aspen
- Pfizer
- Maruishi Pharmaceutical
- Jiangsu Hengrui Medicine
- Lunan Pharmaceutical
- Hikma Pharmaceuticals
- HeBei YiPin Pharmaceutical
- Dechra Pharmaceuticals
- Life Sciences
- Zhejiang AngLiKang Pharmaceutical
- Linde Healthcare
- Air Liquide
- Messer
What is the 10-year outlook for the global Volatile Inhalational Anesthetics market?
What factors are driving Volatile Inhalational Anesthetics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Volatile Inhalational Anesthetics market opportunities vary by end market size?
How does Volatile Inhalational Anesthetics break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Volatile Inhalational Anesthetics Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Volatile Inhalational Anesthetics by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Volatile Inhalational Anesthetics by Country/Region, 2021, 2025 & 2032
2.2 Volatile Inhalational Anesthetics Segment by Type
2.2.1 Heptafluoroane
2.2.2 Desflurane
2.2.3 Isoflurane
2.2.4 Others
2.2.5 Volatile Inhalational Anesthetics Sales by Type
2.2.5.1 Global Volatile Inhalational Anesthetics Sales Market Share by Type (2021-2026)
2.2.5.2 Global Volatile Inhalational Anesthetics Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Volatile Inhalational Anesthetics Sale Price by Type (2021-2026)
2.3 Volatile Inhalational Anesthetics Segment by MAC
2.3.1 Below 3%
2.3.2 Above 3%
2.3.3 Volatile Inhalational Anesthetics Sales by MAC
2.3.3.1 Global Volatile Inhalational Anesthetics Sales Market Share by MAC (2021-2026)
2.3.3.2 Global Volatile Inhalational Anesthetics Revenue and Market Share by MAC (2021-2026)
2.3.3.3 Global Volatile Inhalational Anesthetics Sale Price by MAC (2021-2026)
2.4 Volatile Inhalational Anesthetics Segment by Application
2.4.1 Human Use
2.4.2 Animal Use
2.4.3 Volatile Inhalational Anesthetics Sales by Application
2.4.3.1 Global Volatile Inhalational Anesthetics Sale Market Share by Application (2021-2026)
2.4.3.2 Global Volatile Inhalational Anesthetics Revenue and Market Share by Application (2021-2026)
2.4.3.3 Global Volatile Inhalational Anesthetics Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Volatile Inhalational Anesthetics Breakdown Data by Company
3.1.1 Global Volatile Inhalational Anesthetics Annual Sales by Company (2021-2026)
3.1.2 Global Volatile Inhalational Anesthetics Sales Market Share by Company (2021-2026)
3.2 Global Volatile Inhalational Anesthetics Annual Revenue by Company (2021-2026)
3.2.1 Global Volatile Inhalational Anesthetics Revenue by Company (2021-2026)
3.2.2 Global Volatile Inhalational Anesthetics Revenue Market Share by Company (2021-2026)
3.3 Global Volatile Inhalational Anesthetics Sale Price by Company
3.4 Key Manufacturers Volatile Inhalational Anesthetics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Volatile Inhalational Anesthetics Product Location Distribution
3.4.2 Players Volatile Inhalational Anesthetics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VOLATILE INHALATIONAL ANESTHETICS BY GEOGRAPHIC REGION
4.1 World Historic Volatile Inhalational Anesthetics Market Size by Geographic Region (2021-2026)
4.1.1 Global Volatile Inhalational Anesthetics Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Volatile Inhalational Anesthetics Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Volatile Inhalational Anesthetics Market Size by Country/Region (2021-2026)
4.2.1 Global Volatile Inhalational Anesthetics Annual Sales by Country/Region (2021-2026)
4.2.2 Global Volatile Inhalational Anesthetics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Volatile Inhalational Anesthetics Sales Growth
4.4 APAC Volatile Inhalational Anesthetics Sales Growth
4.5 Europe Volatile Inhalational Anesthetics Sales Growth
4.6 Middle East & Africa Volatile Inhalational Anesthetics Sales Growth
5 AMERICAS
5.1 Americas Volatile Inhalational Anesthetics Sales by Country
5.1.1 Americas Volatile Inhalational Anesthetics Sales by Country (2021-2026)
5.1.2 Americas Volatile Inhalational Anesthetics Revenue by Country (2021-2026)
5.2 Americas Volatile Inhalational Anesthetics Sales by Type (2021-2026)
5.3 Americas Volatile Inhalational Anesthetics Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Volatile Inhalational Anesthetics Sales by Region
6.1.1 APAC Volatile Inhalational Anesthetics Sales by Region (2021-2026)
6.1.2 APAC Volatile Inhalational Anesthetics Revenue by Region (2021-2026)
6.2 APAC Volatile Inhalational Anesthetics Sales by Type (2021-2026)
6.3 APAC Volatile Inhalational Anesthetics Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Volatile Inhalational Anesthetics by Country
7.1.1 Europe Volatile Inhalational Anesthetics Sales by Country (2021-2026)
7.1.2 Europe Volatile Inhalational Anesthetics Revenue by Country (2021-2026)
7.2 Europe Volatile Inhalational Anesthetics Sales by Type (2021-2026)
7.3 Europe Volatile Inhalational Anesthetics Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Volatile Inhalational Anesthetics by Country
8.1.1 Middle East & Africa Volatile Inhalational Anesthetics Sales by Country (2021-2026)
8.1.2 Middle East & Africa Volatile Inhalational Anesthetics Revenue by Country (2021-2026)
8.2 Middle East & Africa Volatile Inhalational Anesthetics Sales by Type (2021-2026)
8.3 Middle East & Africa Volatile Inhalational Anesthetics Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Volatile Inhalational Anesthetics
10.3 Manufacturing Process Analysis of Volatile Inhalational Anesthetics
10.4 Industry Chain Structure of Volatile Inhalational Anesthetics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Volatile Inhalational Anesthetics Distributors
11.3 Volatile Inhalational Anesthetics Customer
12 WORLD FORECAST REVIEW FOR VOLATILE INHALATIONAL ANESTHETICS BY GEOGRAPHIC REGION
12.1 Global Volatile Inhalational Anesthetics Market Size Forecast by Region
12.1.1 Global Volatile Inhalational Anesthetics Forecast by Region (2027-2032)
12.1.2 Global Volatile Inhalational Anesthetics Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Volatile Inhalational Anesthetics Forecast by Type (2027-2032)
12.7 Global Volatile Inhalational Anesthetics Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.1.3 Baxter Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 AbbVie
13.2.1 AbbVie Company Information
13.2.2 AbbVie Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.2.3 AbbVie Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 AbbVie Main Business Overview
13.2.5 AbbVie Latest Developments
13.3 Piramal Critical Care
13.3.1 Piramal Critical Care Company Information
13.3.2 Piramal Critical Care Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.3.3 Piramal Critical Care Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Piramal Critical Care Main Business Overview
13.3.5 Piramal Critical Care Latest Developments
13.4 Fresenius Kabi
13.4.1 Fresenius Kabi Company Information
13.4.2 Fresenius Kabi Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.4.3 Fresenius Kabi Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Fresenius Kabi Main Business Overview
13.4.5 Fresenius Kabi Latest Developments
13.5 Halocarbon
13.5.1 Halocarbon Company Information
13.5.2 Halocarbon Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.5.3 Halocarbon Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Halocarbon Main Business Overview
13.5.5 Halocarbon Latest Developments
13.6 Aspen
13.6.1 Aspen Company Information
13.6.2 Aspen Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.6.3 Aspen Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Aspen Main Business Overview
13.6.5 Aspen Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.7.3 Pfizer Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Maruishi Pharmaceutical
13.8.1 Maruishi Pharmaceutical Company Information
13.8.2 Maruishi Pharmaceutical Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.8.3 Maruishi Pharmaceutical Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Maruishi Pharmaceutical Main Business Overview
13.8.5 Maruishi Pharmaceutical Latest Developments
13.9 Jiangsu Hengrui Medicine
13.9.1 Jiangsu Hengrui Medicine Company Information
13.9.2 Jiangsu Hengrui Medicine Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.9.3 Jiangsu Hengrui Medicine Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Jiangsu Hengrui Medicine Main Business Overview
13.9.5 Jiangsu Hengrui Medicine Latest Developments
13.10 Lunan Pharmaceutical
13.10.1 Lunan Pharmaceutical Company Information
13.10.2 Lunan Pharmaceutical Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.10.3 Lunan Pharmaceutical Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Lunan Pharmaceutical Main Business Overview
13.10.5 Lunan Pharmaceutical Latest Developments
13.11 Hikma Pharmaceuticals
13.11.1 Hikma Pharmaceuticals Company Information
13.11.2 Hikma Pharmaceuticals Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.11.3 Hikma Pharmaceuticals Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Hikma Pharmaceuticals Main Business Overview
13.11.5 Hikma Pharmaceuticals Latest Developments
13.12 HeBei YiPin Pharmaceutical
13.12.1 HeBei YiPin Pharmaceutical Company Information
13.12.2 HeBei YiPin Pharmaceutical Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.12.3 HeBei YiPin Pharmaceutical Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 HeBei YiPin Pharmaceutical Main Business Overview
13.12.5 HeBei YiPin Pharmaceutical Latest Developments
13.13 Dechra Pharmaceuticals
13.13.1 Dechra Pharmaceuticals Company Information
13.13.2 Dechra Pharmaceuticals Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.13.3 Dechra Pharmaceuticals Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Dechra Pharmaceuticals Main Business Overview
13.13.5 Dechra Pharmaceuticals Latest Developments
13.14 Life Sciences
13.14.1 Life Sciences Company Information
13.14.2 Life Sciences Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.14.3 Life Sciences Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Life Sciences Main Business Overview
13.14.5 Life Sciences Latest Developments
13.15 Zhejiang AngLiKang Pharmaceutical
13.15.1 Zhejiang AngLiKang Pharmaceutical Company Information
13.15.2 Zhejiang AngLiKang Pharmaceutical Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.15.3 Zhejiang AngLiKang Pharmaceutical Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Zhejiang AngLiKang Pharmaceutical Main Business Overview
13.15.5 Zhejiang AngLiKang Pharmaceutical Latest Developments
13.16 Linde Healthcare
13.16.1 Linde Healthcare Company Information
13.16.2 Linde Healthcare Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.16.3 Linde Healthcare Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Linde Healthcare Main Business Overview
13.16.5 Linde Healthcare Latest Developments
13.17 Air Liquide
13.17.1 Air Liquide Company Information
13.17.2 Air Liquide Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.17.3 Air Liquide Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Air Liquide Main Business Overview
13.17.5 Air Liquide Latest Developments
13.18 Messer
13.18.1 Messer Company Information
13.18.2 Messer Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.18.3 Messer Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Messer Main Business Overview
13.18.5 Messer Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Volatile Inhalational Anesthetics Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Volatile Inhalational Anesthetics by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Volatile Inhalational Anesthetics by Country/Region, 2021, 2025 & 2032
2.2 Volatile Inhalational Anesthetics Segment by Type
2.2.1 Heptafluoroane
2.2.2 Desflurane
2.2.3 Isoflurane
2.2.4 Others
2.2.5 Volatile Inhalational Anesthetics Sales by Type
2.2.5.1 Global Volatile Inhalational Anesthetics Sales Market Share by Type (2021-2026)
2.2.5.2 Global Volatile Inhalational Anesthetics Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Volatile Inhalational Anesthetics Sale Price by Type (2021-2026)
2.3 Volatile Inhalational Anesthetics Segment by MAC
2.3.1 Below 3%
2.3.2 Above 3%
2.3.3 Volatile Inhalational Anesthetics Sales by MAC
2.3.3.1 Global Volatile Inhalational Anesthetics Sales Market Share by MAC (2021-2026)
2.3.3.2 Global Volatile Inhalational Anesthetics Revenue and Market Share by MAC (2021-2026)
2.3.3.3 Global Volatile Inhalational Anesthetics Sale Price by MAC (2021-2026)
2.4 Volatile Inhalational Anesthetics Segment by Application
2.4.1 Human Use
2.4.2 Animal Use
2.4.3 Volatile Inhalational Anesthetics Sales by Application
2.4.3.1 Global Volatile Inhalational Anesthetics Sale Market Share by Application (2021-2026)
2.4.3.2 Global Volatile Inhalational Anesthetics Revenue and Market Share by Application (2021-2026)
2.4.3.3 Global Volatile Inhalational Anesthetics Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Volatile Inhalational Anesthetics Breakdown Data by Company
3.1.1 Global Volatile Inhalational Anesthetics Annual Sales by Company (2021-2026)
3.1.2 Global Volatile Inhalational Anesthetics Sales Market Share by Company (2021-2026)
3.2 Global Volatile Inhalational Anesthetics Annual Revenue by Company (2021-2026)
3.2.1 Global Volatile Inhalational Anesthetics Revenue by Company (2021-2026)
3.2.2 Global Volatile Inhalational Anesthetics Revenue Market Share by Company (2021-2026)
3.3 Global Volatile Inhalational Anesthetics Sale Price by Company
3.4 Key Manufacturers Volatile Inhalational Anesthetics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Volatile Inhalational Anesthetics Product Location Distribution
3.4.2 Players Volatile Inhalational Anesthetics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VOLATILE INHALATIONAL ANESTHETICS BY GEOGRAPHIC REGION
4.1 World Historic Volatile Inhalational Anesthetics Market Size by Geographic Region (2021-2026)
4.1.1 Global Volatile Inhalational Anesthetics Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Volatile Inhalational Anesthetics Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Volatile Inhalational Anesthetics Market Size by Country/Region (2021-2026)
4.2.1 Global Volatile Inhalational Anesthetics Annual Sales by Country/Region (2021-2026)
4.2.2 Global Volatile Inhalational Anesthetics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Volatile Inhalational Anesthetics Sales Growth
4.4 APAC Volatile Inhalational Anesthetics Sales Growth
4.5 Europe Volatile Inhalational Anesthetics Sales Growth
4.6 Middle East & Africa Volatile Inhalational Anesthetics Sales Growth
5 AMERICAS
5.1 Americas Volatile Inhalational Anesthetics Sales by Country
5.1.1 Americas Volatile Inhalational Anesthetics Sales by Country (2021-2026)
5.1.2 Americas Volatile Inhalational Anesthetics Revenue by Country (2021-2026)
5.2 Americas Volatile Inhalational Anesthetics Sales by Type (2021-2026)
5.3 Americas Volatile Inhalational Anesthetics Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Volatile Inhalational Anesthetics Sales by Region
6.1.1 APAC Volatile Inhalational Anesthetics Sales by Region (2021-2026)
6.1.2 APAC Volatile Inhalational Anesthetics Revenue by Region (2021-2026)
6.2 APAC Volatile Inhalational Anesthetics Sales by Type (2021-2026)
6.3 APAC Volatile Inhalational Anesthetics Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Volatile Inhalational Anesthetics by Country
7.1.1 Europe Volatile Inhalational Anesthetics Sales by Country (2021-2026)
7.1.2 Europe Volatile Inhalational Anesthetics Revenue by Country (2021-2026)
7.2 Europe Volatile Inhalational Anesthetics Sales by Type (2021-2026)
7.3 Europe Volatile Inhalational Anesthetics Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Volatile Inhalational Anesthetics by Country
8.1.1 Middle East & Africa Volatile Inhalational Anesthetics Sales by Country (2021-2026)
8.1.2 Middle East & Africa Volatile Inhalational Anesthetics Revenue by Country (2021-2026)
8.2 Middle East & Africa Volatile Inhalational Anesthetics Sales by Type (2021-2026)
8.3 Middle East & Africa Volatile Inhalational Anesthetics Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Volatile Inhalational Anesthetics
10.3 Manufacturing Process Analysis of Volatile Inhalational Anesthetics
10.4 Industry Chain Structure of Volatile Inhalational Anesthetics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Volatile Inhalational Anesthetics Distributors
11.3 Volatile Inhalational Anesthetics Customer
12 WORLD FORECAST REVIEW FOR VOLATILE INHALATIONAL ANESTHETICS BY GEOGRAPHIC REGION
12.1 Global Volatile Inhalational Anesthetics Market Size Forecast by Region
12.1.1 Global Volatile Inhalational Anesthetics Forecast by Region (2027-2032)
12.1.2 Global Volatile Inhalational Anesthetics Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Volatile Inhalational Anesthetics Forecast by Type (2027-2032)
12.7 Global Volatile Inhalational Anesthetics Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.1.3 Baxter Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 AbbVie
13.2.1 AbbVie Company Information
13.2.2 AbbVie Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.2.3 AbbVie Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 AbbVie Main Business Overview
13.2.5 AbbVie Latest Developments
13.3 Piramal Critical Care
13.3.1 Piramal Critical Care Company Information
13.3.2 Piramal Critical Care Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.3.3 Piramal Critical Care Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Piramal Critical Care Main Business Overview
13.3.5 Piramal Critical Care Latest Developments
13.4 Fresenius Kabi
13.4.1 Fresenius Kabi Company Information
13.4.2 Fresenius Kabi Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.4.3 Fresenius Kabi Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Fresenius Kabi Main Business Overview
13.4.5 Fresenius Kabi Latest Developments
13.5 Halocarbon
13.5.1 Halocarbon Company Information
13.5.2 Halocarbon Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.5.3 Halocarbon Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Halocarbon Main Business Overview
13.5.5 Halocarbon Latest Developments
13.6 Aspen
13.6.1 Aspen Company Information
13.6.2 Aspen Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.6.3 Aspen Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Aspen Main Business Overview
13.6.5 Aspen Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.7.3 Pfizer Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Maruishi Pharmaceutical
13.8.1 Maruishi Pharmaceutical Company Information
13.8.2 Maruishi Pharmaceutical Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.8.3 Maruishi Pharmaceutical Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Maruishi Pharmaceutical Main Business Overview
13.8.5 Maruishi Pharmaceutical Latest Developments
13.9 Jiangsu Hengrui Medicine
13.9.1 Jiangsu Hengrui Medicine Company Information
13.9.2 Jiangsu Hengrui Medicine Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.9.3 Jiangsu Hengrui Medicine Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Jiangsu Hengrui Medicine Main Business Overview
13.9.5 Jiangsu Hengrui Medicine Latest Developments
13.10 Lunan Pharmaceutical
13.10.1 Lunan Pharmaceutical Company Information
13.10.2 Lunan Pharmaceutical Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.10.3 Lunan Pharmaceutical Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Lunan Pharmaceutical Main Business Overview
13.10.5 Lunan Pharmaceutical Latest Developments
13.11 Hikma Pharmaceuticals
13.11.1 Hikma Pharmaceuticals Company Information
13.11.2 Hikma Pharmaceuticals Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.11.3 Hikma Pharmaceuticals Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Hikma Pharmaceuticals Main Business Overview
13.11.5 Hikma Pharmaceuticals Latest Developments
13.12 HeBei YiPin Pharmaceutical
13.12.1 HeBei YiPin Pharmaceutical Company Information
13.12.2 HeBei YiPin Pharmaceutical Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.12.3 HeBei YiPin Pharmaceutical Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 HeBei YiPin Pharmaceutical Main Business Overview
13.12.5 HeBei YiPin Pharmaceutical Latest Developments
13.13 Dechra Pharmaceuticals
13.13.1 Dechra Pharmaceuticals Company Information
13.13.2 Dechra Pharmaceuticals Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.13.3 Dechra Pharmaceuticals Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Dechra Pharmaceuticals Main Business Overview
13.13.5 Dechra Pharmaceuticals Latest Developments
13.14 Life Sciences
13.14.1 Life Sciences Company Information
13.14.2 Life Sciences Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.14.3 Life Sciences Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Life Sciences Main Business Overview
13.14.5 Life Sciences Latest Developments
13.15 Zhejiang AngLiKang Pharmaceutical
13.15.1 Zhejiang AngLiKang Pharmaceutical Company Information
13.15.2 Zhejiang AngLiKang Pharmaceutical Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.15.3 Zhejiang AngLiKang Pharmaceutical Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Zhejiang AngLiKang Pharmaceutical Main Business Overview
13.15.5 Zhejiang AngLiKang Pharmaceutical Latest Developments
13.16 Linde Healthcare
13.16.1 Linde Healthcare Company Information
13.16.2 Linde Healthcare Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.16.3 Linde Healthcare Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Linde Healthcare Main Business Overview
13.16.5 Linde Healthcare Latest Developments
13.17 Air Liquide
13.17.1 Air Liquide Company Information
13.17.2 Air Liquide Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.17.3 Air Liquide Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Air Liquide Main Business Overview
13.17.5 Air Liquide Latest Developments
13.18 Messer
13.18.1 Messer Company Information
13.18.2 Messer Volatile Inhalational Anesthetics Product Portfolios and Specifications
13.18.3 Messer Volatile Inhalational Anesthetics Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Messer Main Business Overview
13.18.5 Messer Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Volatile Inhalational Anesthetics Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Volatile Inhalational Anesthetics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Heptafluoroane
Table 4. Major Players of Desflurane
Table 5. Major Players of Isoflurane
Table 6. Major Players of Others
Table 7. Global Volatile Inhalational Anesthetics Sales by Type (2021-2026) & (Tons)
Table 8. Global Volatile Inhalational Anesthetics Sales Market Share by Type (2021-2026)
Table 9. Global Volatile Inhalational Anesthetics Revenue by Type (2021-2026) & ($ million)
Table 10. Global Volatile Inhalational Anesthetics Revenue Market Share by Type (2021-2026)
Table 11. Global Volatile Inhalational Anesthetics Sale Price by Type (2021-2026) & (US$/kg)
Table 12. Major Players of Below 3%
Table 13. Major Players of Above 3%
Table 14. Global Volatile Inhalational Anesthetics Sales by MAC (2021-2026) & (Tons)
Table 15. Global Volatile Inhalational Anesthetics Sales Market Share by MAC (2021-2026)
Table 16. Global Volatile Inhalational Anesthetics Revenue by MAC (2021-2026) & ($ million)
Table 17. Global Volatile Inhalational Anesthetics Revenue Market Share by MAC (2021-2026)
Table 18. Global Volatile Inhalational Anesthetics Sale Price by MAC (2021-2026) & (US$/kg)
Table 19. Global Volatile Inhalational Anesthetics Sale by Application (2021-2026) & (Tons)
Table 20. Global Volatile Inhalational Anesthetics Sale Market Share by Application (2021-2026)
Table 21. Global Volatile Inhalational Anesthetics Revenue by Application (2021-2026) & ($ million)
Table 22. Global Volatile Inhalational Anesthetics Revenue Market Share by Application (2021-2026)
Table 23. Global Volatile Inhalational Anesthetics Sale Price by Application (2021-2026) & (US$/kg)
Table 24. Global Volatile Inhalational Anesthetics Sales by Company (2021-2026) & (Tons)
Table 25. Global Volatile Inhalational Anesthetics Sales Market Share by Company (2021-2026)
Table 26. Global Volatile Inhalational Anesthetics Revenue by Company (2021-2026) & ($ millions)
Table 27. Global Volatile Inhalational Anesthetics Revenue Market Share by Company (2021-2026)
Table 28. Global Volatile Inhalational Anesthetics Sale Price by Company (2021-2026) & (US$/kg)
Table 29. Key Manufacturers Volatile Inhalational Anesthetics Producing Area Distribution and Sales Area
Table 30. Players Volatile Inhalational Anesthetics Products Offered
Table 31. Volatile Inhalational Anesthetics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 32. New Products and Potential Entrants
Table 33. Market M&A Activity & Strategy
Table 34. Global Volatile Inhalational Anesthetics Sales by Geographic Region (2021-2026) & (Tons)
Table 35. Global Volatile Inhalational Anesthetics Sales Market Share Geographic Region (2021-2026)
Table 36. Global Volatile Inhalational Anesthetics Revenue by Geographic Region (2021-2026) & ($ millions)
Table 37. Global Volatile Inhalational Anesthetics Revenue Market Share by Geographic Region (2021-2026)
Table 38. Global Volatile Inhalational Anesthetics Sales by Country/Region (2021-2026) & (Tons)
Table 39. Global Volatile Inhalational Anesthetics Sales Market Share by Country/Region (2021-2026)
Table 40. Global Volatile Inhalational Anesthetics Revenue by Country/Region (2021-2026) & ($ millions)
Table 41. Global Volatile Inhalational Anesthetics Revenue Market Share by Country/Region (2021-2026)
Table 42. Americas Volatile Inhalational Anesthetics Sales by Country (2021-2026) & (Tons)
Table 43. Americas Volatile Inhalational Anesthetics Sales Market Share by Country (2021-2026)
Table 44. Americas Volatile Inhalational Anesthetics Revenue by Country (2021-2026) & ($ millions)
Table 45. Americas Volatile Inhalational Anesthetics Sales by Type (2021-2026) & (Tons)
Table 46. Americas Volatile Inhalational Anesthetics Sales by Application (2021-2026) & (Tons)
Table 47. APAC Volatile Inhalational Anesthetics Sales by Region (2021-2026) & (Tons)
Table 48. APAC Volatile Inhalational Anesthetics Sales Market Share by Region (2021-2026)
Table 49. APAC Volatile Inhalational Anesthetics Revenue by Region (2021-2026) & ($ millions)
Table 50. APAC Volatile Inhalational Anesthetics Sales by Type (2021-2026) & (Tons)
Table 51. APAC Volatile Inhalational Anesthetics Sales by Application (2021-2026) & (Tons)
Table 52. Europe Volatile Inhalational Anesthetics Sales by Country (2021-2026) & (Tons)
Table 53. Europe Volatile Inhalational Anesthetics Revenue by Country (2021-2026) & ($ millions)
Table 54. Europe Volatile Inhalational Anesthetics Sales by Type (2021-2026) & (Tons)
Table 55. Europe Volatile Inhalational Anesthetics Sales by Application (2021-2026) & (Tons)
Table 56. Middle East & Africa Volatile Inhalational Anesthetics Sales by Country (2021-2026) & (Tons)
Table 57. Middle East & Africa Volatile Inhalational Anesthetics Revenue Market Share by Country (2021-2026)
Table 58. Middle East & Africa Volatile Inhalational Anesthetics Sales by Type (2021-2026) & (Tons)
Table 59. Middle East & Africa Volatile Inhalational Anesthetics Sales by Application (2021-2026) & (Tons)
Table 60. Key Market Drivers & Growth Opportunities of Volatile Inhalational Anesthetics
Table 61. Key Market Challenges & Risks of Volatile Inhalational Anesthetics
Table 62. Key Industry Trends of Volatile Inhalational Anesthetics
Table 63. Volatile Inhalational Anesthetics Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Volatile Inhalational Anesthetics Distributors List
Table 66. Volatile Inhalational Anesthetics Customer List
Table 67. Global Volatile Inhalational Anesthetics Sales Forecast by Region (2027-2032) & (Tons)
Table 68. Global Volatile Inhalational Anesthetics Revenue Forecast by Region (2027-2032) & ($ millions)
Table 69. Americas Volatile Inhalational Anesthetics Sales Forecast by Country (2027-2032) & (Tons)
Table 70. Americas Volatile Inhalational Anesthetics Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. APAC Volatile Inhalational Anesthetics Sales Forecast by Region (2027-2032) & (Tons)
Table 72. APAC Volatile Inhalational Anesthetics Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 73. Europe Volatile Inhalational Anesthetics Sales Forecast by Country (2027-2032) & (Tons)
Table 74. Europe Volatile Inhalational Anesthetics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 75. Middle East & Africa Volatile Inhalational Anesthetics Sales Forecast by Country (2027-2032) & (Tons)
Table 76. Middle East & Africa Volatile Inhalational Anesthetics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. Global Volatile Inhalational Anesthetics Sales Forecast by Type (2027-2032) & (Tons)
Table 78. Global Volatile Inhalational Anesthetics Revenue Forecast by Type (2027-2032) & ($ millions)
Table 79. Global Volatile Inhalational Anesthetics Sales Forecast by Application (2027-2032) & (Tons)
Table 80. Global Volatile Inhalational Anesthetics Revenue Forecast by Application (2027-2032) & ($ millions)
Table 81. Baxter Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 82. Baxter Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 83. Baxter Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 84. Baxter Main Business
Table 85. Baxter Latest Developments
Table 86. AbbVie Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 87. AbbVie Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 88. AbbVie Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 89. AbbVie Main Business
Table 90. AbbVie Latest Developments
Table 91. Piramal Critical Care Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 92. Piramal Critical Care Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 93. Piramal Critical Care Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 94. Piramal Critical Care Main Business
Table 95. Piramal Critical Care Latest Developments
Table 96. Fresenius Kabi Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 97. Fresenius Kabi Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 98. Fresenius Kabi Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 99. Fresenius Kabi Main Business
Table 100. Fresenius Kabi Latest Developments
Table 101. Halocarbon Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 102. Halocarbon Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 103. Halocarbon Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 104. Halocarbon Main Business
Table 105. Halocarbon Latest Developments
Table 106. Aspen Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 107. Aspen Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 108. Aspen Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 109. Aspen Main Business
Table 110. Aspen Latest Developments
Table 111. Pfizer Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 112. Pfizer Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 113. Pfizer Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 114. Pfizer Main Business
Table 115. Pfizer Latest Developments
Table 116. Maruishi Pharmaceutical Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 117. Maruishi Pharmaceutical Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 118. Maruishi Pharmaceutical Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 119. Maruishi Pharmaceutical Main Business
Table 120. Maruishi Pharmaceutical Latest Developments
Table 121. Jiangsu Hengrui Medicine Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 122. Jiangsu Hengrui Medicine Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 123. Jiangsu Hengrui Medicine Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 124. Jiangsu Hengrui Medicine Main Business
Table 125. Jiangsu Hengrui Medicine Latest Developments
Table 126. Lunan Pharmaceutical Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 127. Lunan Pharmaceutical Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 128. Lunan Pharmaceutical Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 129. Lunan Pharmaceutical Main Business
Table 130. Lunan Pharmaceutical Latest Developments
Table 131. Hikma Pharmaceuticals Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 132. Hikma Pharmaceuticals Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 133. Hikma Pharmaceuticals Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 134. Hikma Pharmaceuticals Main Business
Table 135. Hikma Pharmaceuticals Latest Developments
Table 136. HeBei YiPin Pharmaceutical Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 137. HeBei YiPin Pharmaceutical Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 138. HeBei YiPin Pharmaceutical Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 139. HeBei YiPin Pharmaceutical Main Business
Table 140. HeBei YiPin Pharmaceutical Latest Developments
Table 141. Dechra Pharmaceuticals Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 142. Dechra Pharmaceuticals Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 143. Dechra Pharmaceuticals Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 144. Dechra Pharmaceuticals Main Business
Table 145. Dechra Pharmaceuticals Latest Developments
Table 146. Life Sciences Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 147. Life Sciences Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 148. Life Sciences Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 149. Life Sciences Main Business
Table 150. Life Sciences Latest Developments
Table 151. Zhejiang AngLiKang Pharmaceutical Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 152. Zhejiang AngLiKang Pharmaceutical Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 153. Zhejiang AngLiKang Pharmaceutical Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 154. Zhejiang AngLiKang Pharmaceutical Main Business
Table 155. Zhejiang AngLiKang Pharmaceutical Latest Developments
Table 156. Linde Healthcare Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 157. Linde Healthcare Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 158. Linde Healthcare Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 159. Linde Healthcare Main Business
Table 160. Linde Healthcare Latest Developments
Table 161. Air Liquide Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 162. Air Liquide Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 163. Air Liquide Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 164. Air Liquide Main Business
Table 165. Air Liquide Latest Developments
Table 166. Messer Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 167. Messer Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 168. Messer Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 169. Messer Main Business
Table 170. Messer Latest Developments
Table 1. Volatile Inhalational Anesthetics Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Volatile Inhalational Anesthetics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Heptafluoroane
Table 4. Major Players of Desflurane
Table 5. Major Players of Isoflurane
Table 6. Major Players of Others
Table 7. Global Volatile Inhalational Anesthetics Sales by Type (2021-2026) & (Tons)
Table 8. Global Volatile Inhalational Anesthetics Sales Market Share by Type (2021-2026)
Table 9. Global Volatile Inhalational Anesthetics Revenue by Type (2021-2026) & ($ million)
Table 10. Global Volatile Inhalational Anesthetics Revenue Market Share by Type (2021-2026)
Table 11. Global Volatile Inhalational Anesthetics Sale Price by Type (2021-2026) & (US$/kg)
Table 12. Major Players of Below 3%
Table 13. Major Players of Above 3%
Table 14. Global Volatile Inhalational Anesthetics Sales by MAC (2021-2026) & (Tons)
Table 15. Global Volatile Inhalational Anesthetics Sales Market Share by MAC (2021-2026)
Table 16. Global Volatile Inhalational Anesthetics Revenue by MAC (2021-2026) & ($ million)
Table 17. Global Volatile Inhalational Anesthetics Revenue Market Share by MAC (2021-2026)
Table 18. Global Volatile Inhalational Anesthetics Sale Price by MAC (2021-2026) & (US$/kg)
Table 19. Global Volatile Inhalational Anesthetics Sale by Application (2021-2026) & (Tons)
Table 20. Global Volatile Inhalational Anesthetics Sale Market Share by Application (2021-2026)
Table 21. Global Volatile Inhalational Anesthetics Revenue by Application (2021-2026) & ($ million)
Table 22. Global Volatile Inhalational Anesthetics Revenue Market Share by Application (2021-2026)
Table 23. Global Volatile Inhalational Anesthetics Sale Price by Application (2021-2026) & (US$/kg)
Table 24. Global Volatile Inhalational Anesthetics Sales by Company (2021-2026) & (Tons)
Table 25. Global Volatile Inhalational Anesthetics Sales Market Share by Company (2021-2026)
Table 26. Global Volatile Inhalational Anesthetics Revenue by Company (2021-2026) & ($ millions)
Table 27. Global Volatile Inhalational Anesthetics Revenue Market Share by Company (2021-2026)
Table 28. Global Volatile Inhalational Anesthetics Sale Price by Company (2021-2026) & (US$/kg)
Table 29. Key Manufacturers Volatile Inhalational Anesthetics Producing Area Distribution and Sales Area
Table 30. Players Volatile Inhalational Anesthetics Products Offered
Table 31. Volatile Inhalational Anesthetics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 32. New Products and Potential Entrants
Table 33. Market M&A Activity & Strategy
Table 34. Global Volatile Inhalational Anesthetics Sales by Geographic Region (2021-2026) & (Tons)
Table 35. Global Volatile Inhalational Anesthetics Sales Market Share Geographic Region (2021-2026)
Table 36. Global Volatile Inhalational Anesthetics Revenue by Geographic Region (2021-2026) & ($ millions)
Table 37. Global Volatile Inhalational Anesthetics Revenue Market Share by Geographic Region (2021-2026)
Table 38. Global Volatile Inhalational Anesthetics Sales by Country/Region (2021-2026) & (Tons)
Table 39. Global Volatile Inhalational Anesthetics Sales Market Share by Country/Region (2021-2026)
Table 40. Global Volatile Inhalational Anesthetics Revenue by Country/Region (2021-2026) & ($ millions)
Table 41. Global Volatile Inhalational Anesthetics Revenue Market Share by Country/Region (2021-2026)
Table 42. Americas Volatile Inhalational Anesthetics Sales by Country (2021-2026) & (Tons)
Table 43. Americas Volatile Inhalational Anesthetics Sales Market Share by Country (2021-2026)
Table 44. Americas Volatile Inhalational Anesthetics Revenue by Country (2021-2026) & ($ millions)
Table 45. Americas Volatile Inhalational Anesthetics Sales by Type (2021-2026) & (Tons)
Table 46. Americas Volatile Inhalational Anesthetics Sales by Application (2021-2026) & (Tons)
Table 47. APAC Volatile Inhalational Anesthetics Sales by Region (2021-2026) & (Tons)
Table 48. APAC Volatile Inhalational Anesthetics Sales Market Share by Region (2021-2026)
Table 49. APAC Volatile Inhalational Anesthetics Revenue by Region (2021-2026) & ($ millions)
Table 50. APAC Volatile Inhalational Anesthetics Sales by Type (2021-2026) & (Tons)
Table 51. APAC Volatile Inhalational Anesthetics Sales by Application (2021-2026) & (Tons)
Table 52. Europe Volatile Inhalational Anesthetics Sales by Country (2021-2026) & (Tons)
Table 53. Europe Volatile Inhalational Anesthetics Revenue by Country (2021-2026) & ($ millions)
Table 54. Europe Volatile Inhalational Anesthetics Sales by Type (2021-2026) & (Tons)
Table 55. Europe Volatile Inhalational Anesthetics Sales by Application (2021-2026) & (Tons)
Table 56. Middle East & Africa Volatile Inhalational Anesthetics Sales by Country (2021-2026) & (Tons)
Table 57. Middle East & Africa Volatile Inhalational Anesthetics Revenue Market Share by Country (2021-2026)
Table 58. Middle East & Africa Volatile Inhalational Anesthetics Sales by Type (2021-2026) & (Tons)
Table 59. Middle East & Africa Volatile Inhalational Anesthetics Sales by Application (2021-2026) & (Tons)
Table 60. Key Market Drivers & Growth Opportunities of Volatile Inhalational Anesthetics
Table 61. Key Market Challenges & Risks of Volatile Inhalational Anesthetics
Table 62. Key Industry Trends of Volatile Inhalational Anesthetics
Table 63. Volatile Inhalational Anesthetics Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Volatile Inhalational Anesthetics Distributors List
Table 66. Volatile Inhalational Anesthetics Customer List
Table 67. Global Volatile Inhalational Anesthetics Sales Forecast by Region (2027-2032) & (Tons)
Table 68. Global Volatile Inhalational Anesthetics Revenue Forecast by Region (2027-2032) & ($ millions)
Table 69. Americas Volatile Inhalational Anesthetics Sales Forecast by Country (2027-2032) & (Tons)
Table 70. Americas Volatile Inhalational Anesthetics Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. APAC Volatile Inhalational Anesthetics Sales Forecast by Region (2027-2032) & (Tons)
Table 72. APAC Volatile Inhalational Anesthetics Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 73. Europe Volatile Inhalational Anesthetics Sales Forecast by Country (2027-2032) & (Tons)
Table 74. Europe Volatile Inhalational Anesthetics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 75. Middle East & Africa Volatile Inhalational Anesthetics Sales Forecast by Country (2027-2032) & (Tons)
Table 76. Middle East & Africa Volatile Inhalational Anesthetics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. Global Volatile Inhalational Anesthetics Sales Forecast by Type (2027-2032) & (Tons)
Table 78. Global Volatile Inhalational Anesthetics Revenue Forecast by Type (2027-2032) & ($ millions)
Table 79. Global Volatile Inhalational Anesthetics Sales Forecast by Application (2027-2032) & (Tons)
Table 80. Global Volatile Inhalational Anesthetics Revenue Forecast by Application (2027-2032) & ($ millions)
Table 81. Baxter Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 82. Baxter Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 83. Baxter Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 84. Baxter Main Business
Table 85. Baxter Latest Developments
Table 86. AbbVie Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 87. AbbVie Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 88. AbbVie Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 89. AbbVie Main Business
Table 90. AbbVie Latest Developments
Table 91. Piramal Critical Care Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 92. Piramal Critical Care Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 93. Piramal Critical Care Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 94. Piramal Critical Care Main Business
Table 95. Piramal Critical Care Latest Developments
Table 96. Fresenius Kabi Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 97. Fresenius Kabi Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 98. Fresenius Kabi Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 99. Fresenius Kabi Main Business
Table 100. Fresenius Kabi Latest Developments
Table 101. Halocarbon Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 102. Halocarbon Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 103. Halocarbon Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 104. Halocarbon Main Business
Table 105. Halocarbon Latest Developments
Table 106. Aspen Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 107. Aspen Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 108. Aspen Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 109. Aspen Main Business
Table 110. Aspen Latest Developments
Table 111. Pfizer Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 112. Pfizer Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 113. Pfizer Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 114. Pfizer Main Business
Table 115. Pfizer Latest Developments
Table 116. Maruishi Pharmaceutical Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 117. Maruishi Pharmaceutical Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 118. Maruishi Pharmaceutical Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 119. Maruishi Pharmaceutical Main Business
Table 120. Maruishi Pharmaceutical Latest Developments
Table 121. Jiangsu Hengrui Medicine Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 122. Jiangsu Hengrui Medicine Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 123. Jiangsu Hengrui Medicine Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 124. Jiangsu Hengrui Medicine Main Business
Table 125. Jiangsu Hengrui Medicine Latest Developments
Table 126. Lunan Pharmaceutical Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 127. Lunan Pharmaceutical Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 128. Lunan Pharmaceutical Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 129. Lunan Pharmaceutical Main Business
Table 130. Lunan Pharmaceutical Latest Developments
Table 131. Hikma Pharmaceuticals Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 132. Hikma Pharmaceuticals Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 133. Hikma Pharmaceuticals Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 134. Hikma Pharmaceuticals Main Business
Table 135. Hikma Pharmaceuticals Latest Developments
Table 136. HeBei YiPin Pharmaceutical Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 137. HeBei YiPin Pharmaceutical Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 138. HeBei YiPin Pharmaceutical Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 139. HeBei YiPin Pharmaceutical Main Business
Table 140. HeBei YiPin Pharmaceutical Latest Developments
Table 141. Dechra Pharmaceuticals Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 142. Dechra Pharmaceuticals Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 143. Dechra Pharmaceuticals Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 144. Dechra Pharmaceuticals Main Business
Table 145. Dechra Pharmaceuticals Latest Developments
Table 146. Life Sciences Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 147. Life Sciences Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 148. Life Sciences Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 149. Life Sciences Main Business
Table 150. Life Sciences Latest Developments
Table 151. Zhejiang AngLiKang Pharmaceutical Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 152. Zhejiang AngLiKang Pharmaceutical Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 153. Zhejiang AngLiKang Pharmaceutical Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 154. Zhejiang AngLiKang Pharmaceutical Main Business
Table 155. Zhejiang AngLiKang Pharmaceutical Latest Developments
Table 156. Linde Healthcare Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 157. Linde Healthcare Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 158. Linde Healthcare Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 159. Linde Healthcare Main Business
Table 160. Linde Healthcare Latest Developments
Table 161. Air Liquide Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 162. Air Liquide Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 163. Air Liquide Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 164. Air Liquide Main Business
Table 165. Air Liquide Latest Developments
Table 166. Messer Basic Information, Volatile Inhalational Anesthetics Manufacturing Base, Sales Area and Its Competitors
Table 167. Messer Volatile Inhalational Anesthetics Product Portfolios and Specifications
Table 168. Messer Volatile Inhalational Anesthetics Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 169. Messer Main Business
Table 170. Messer Latest Developments
LIST OF FIGURES
Figure 1. Picture of Volatile Inhalational Anesthetics
Figure 2. Volatile Inhalational Anesthetics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Volatile Inhalational Anesthetics Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Volatile Inhalational Anesthetics Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Volatile Inhalational Anesthetics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Volatile Inhalational Anesthetics Sales Market Share by Country/Region (2025)
Figure 10. Volatile Inhalational Anesthetics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Heptafluoroane
Figure 12. Product Picture of Desflurane
Figure 13. Product Picture of Isoflurane
Figure 14. Product Picture of Others
Figure 15. Global Volatile Inhalational Anesthetics Sales Market Share by Type in 2026
Figure 16. Global Volatile Inhalational Anesthetics Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Below 3%
Figure 18. Product Picture of Above 3%
Figure 19. Global Volatile Inhalational Anesthetics Sales Market Share by MAC in 2026
Figure 20. Global Volatile Inhalational Anesthetics Revenue Market Share by MAC (2021-2026)
Figure 21. Volatile Inhalational Anesthetics Consumed in Human Use
Figure 22. Global Volatile Inhalational Anesthetics Market: Human Use (2021-2026) & (Tons)
Figure 23. Volatile Inhalational Anesthetics Consumed in Animal Use
Figure 24. Global Volatile Inhalational Anesthetics Market: Animal Use (2021-2026) & (Tons)
Figure 25. Global Volatile Inhalational Anesthetics Sale Market Share by Application (2025)
Figure 26. Global Volatile Inhalational Anesthetics Revenue Market Share by Application in 2026
Figure 27. Volatile Inhalational Anesthetics Sales by Company in 2026 (Tons)
Figure 28. Global Volatile Inhalational Anesthetics Sales Market Share by Company in 2026
Figure 29. Volatile Inhalational Anesthetics Revenue by Company in 2026 ($ millions)
Figure 30. Global Volatile Inhalational Anesthetics Revenue Market Share by Company in 2026
Figure 31. Global Volatile Inhalational Anesthetics Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Volatile Inhalational Anesthetics Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Volatile Inhalational Anesthetics Sales 2021-2026 (Tons)
Figure 34. Americas Volatile Inhalational Anesthetics Revenue 2021-2026 ($ millions)
Figure 35. APAC Volatile Inhalational Anesthetics Sales 2021-2026 (Tons)
Figure 36. APAC Volatile Inhalational Anesthetics Revenue 2021-2026 ($ millions)
Figure 37. Europe Volatile Inhalational Anesthetics Sales 2021-2026 (Tons)
Figure 38. Europe Volatile Inhalational Anesthetics Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Volatile Inhalational Anesthetics Sales 2021-2026 (Tons)
Figure 40. Middle East & Africa Volatile Inhalational Anesthetics Revenue 2021-2026 ($ millions)
Figure 41. Americas Volatile Inhalational Anesthetics Sales Market Share by Country in 2026
Figure 42. Americas Volatile Inhalational Anesthetics Revenue Market Share by Country (2021-2026)
Figure 43. Americas Volatile Inhalational Anesthetics Sales Market Share by Type (2021-2026)
Figure 44. Americas Volatile Inhalational Anesthetics Sales Market Share by Application (2021-2026)
Figure 45. United States Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Volatile Inhalational Anesthetics Sales Market Share by Region in 2026
Figure 50. APAC Volatile Inhalational Anesthetics Revenue Market Share by Region (2021-2026)
Figure 51. APAC Volatile Inhalational Anesthetics Sales Market Share by Type (2021-2026)
Figure 52. APAC Volatile Inhalational Anesthetics Sales Market Share by Application (2021-2026)
Figure 53. China Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 57. India Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Volatile Inhalational Anesthetics Sales Market Share by Country in 2026
Figure 61. Europe Volatile Inhalational Anesthetics Revenue Market Share by Country (2021-2026)
Figure 62. Europe Volatile Inhalational Anesthetics Sales Market Share by Type (2021-2026)
Figure 63. Europe Volatile Inhalational Anesthetics Sales Market Share by Application (2021-2026)
Figure 64. Germany Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 65. France Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Volatile Inhalational Anesthetics Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Volatile Inhalational Anesthetics Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Volatile Inhalational Anesthetics Sales Market Share by Application (2021-2026)
Figure 72. Egypt Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Volatile Inhalational Anesthetics in 2026
Figure 78. Manufacturing Process Analysis of Volatile Inhalational Anesthetics
Figure 79. Industry Chain Structure of Volatile Inhalational Anesthetics
Figure 80. Channels of Distribution
Figure 81. Global Volatile Inhalational Anesthetics Sales Market Forecast by Region (2027-2032)
Figure 82. Global Volatile Inhalational Anesthetics Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Volatile Inhalational Anesthetics Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Volatile Inhalational Anesthetics Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Volatile Inhalational Anesthetics Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Volatile Inhalational Anesthetics Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Volatile Inhalational Anesthetics
Figure 2. Volatile Inhalational Anesthetics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Volatile Inhalational Anesthetics Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Volatile Inhalational Anesthetics Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Volatile Inhalational Anesthetics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Volatile Inhalational Anesthetics Sales Market Share by Country/Region (2025)
Figure 10. Volatile Inhalational Anesthetics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Heptafluoroane
Figure 12. Product Picture of Desflurane
Figure 13. Product Picture of Isoflurane
Figure 14. Product Picture of Others
Figure 15. Global Volatile Inhalational Anesthetics Sales Market Share by Type in 2026
Figure 16. Global Volatile Inhalational Anesthetics Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Below 3%
Figure 18. Product Picture of Above 3%
Figure 19. Global Volatile Inhalational Anesthetics Sales Market Share by MAC in 2026
Figure 20. Global Volatile Inhalational Anesthetics Revenue Market Share by MAC (2021-2026)
Figure 21. Volatile Inhalational Anesthetics Consumed in Human Use
Figure 22. Global Volatile Inhalational Anesthetics Market: Human Use (2021-2026) & (Tons)
Figure 23. Volatile Inhalational Anesthetics Consumed in Animal Use
Figure 24. Global Volatile Inhalational Anesthetics Market: Animal Use (2021-2026) & (Tons)
Figure 25. Global Volatile Inhalational Anesthetics Sale Market Share by Application (2025)
Figure 26. Global Volatile Inhalational Anesthetics Revenue Market Share by Application in 2026
Figure 27. Volatile Inhalational Anesthetics Sales by Company in 2026 (Tons)
Figure 28. Global Volatile Inhalational Anesthetics Sales Market Share by Company in 2026
Figure 29. Volatile Inhalational Anesthetics Revenue by Company in 2026 ($ millions)
Figure 30. Global Volatile Inhalational Anesthetics Revenue Market Share by Company in 2026
Figure 31. Global Volatile Inhalational Anesthetics Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Volatile Inhalational Anesthetics Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Volatile Inhalational Anesthetics Sales 2021-2026 (Tons)
Figure 34. Americas Volatile Inhalational Anesthetics Revenue 2021-2026 ($ millions)
Figure 35. APAC Volatile Inhalational Anesthetics Sales 2021-2026 (Tons)
Figure 36. APAC Volatile Inhalational Anesthetics Revenue 2021-2026 ($ millions)
Figure 37. Europe Volatile Inhalational Anesthetics Sales 2021-2026 (Tons)
Figure 38. Europe Volatile Inhalational Anesthetics Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Volatile Inhalational Anesthetics Sales 2021-2026 (Tons)
Figure 40. Middle East & Africa Volatile Inhalational Anesthetics Revenue 2021-2026 ($ millions)
Figure 41. Americas Volatile Inhalational Anesthetics Sales Market Share by Country in 2026
Figure 42. Americas Volatile Inhalational Anesthetics Revenue Market Share by Country (2021-2026)
Figure 43. Americas Volatile Inhalational Anesthetics Sales Market Share by Type (2021-2026)
Figure 44. Americas Volatile Inhalational Anesthetics Sales Market Share by Application (2021-2026)
Figure 45. United States Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Volatile Inhalational Anesthetics Sales Market Share by Region in 2026
Figure 50. APAC Volatile Inhalational Anesthetics Revenue Market Share by Region (2021-2026)
Figure 51. APAC Volatile Inhalational Anesthetics Sales Market Share by Type (2021-2026)
Figure 52. APAC Volatile Inhalational Anesthetics Sales Market Share by Application (2021-2026)
Figure 53. China Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 57. India Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Volatile Inhalational Anesthetics Sales Market Share by Country in 2026
Figure 61. Europe Volatile Inhalational Anesthetics Revenue Market Share by Country (2021-2026)
Figure 62. Europe Volatile Inhalational Anesthetics Sales Market Share by Type (2021-2026)
Figure 63. Europe Volatile Inhalational Anesthetics Sales Market Share by Application (2021-2026)
Figure 64. Germany Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 65. France Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Volatile Inhalational Anesthetics Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Volatile Inhalational Anesthetics Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Volatile Inhalational Anesthetics Sales Market Share by Application (2021-2026)
Figure 72. Egypt Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Volatile Inhalational Anesthetics Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Volatile Inhalational Anesthetics in 2026
Figure 78. Manufacturing Process Analysis of Volatile Inhalational Anesthetics
Figure 79. Industry Chain Structure of Volatile Inhalational Anesthetics
Figure 80. Channels of Distribution
Figure 81. Global Volatile Inhalational Anesthetics Sales Market Forecast by Region (2027-2032)
Figure 82. Global Volatile Inhalational Anesthetics Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Volatile Inhalational Anesthetics Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Volatile Inhalational Anesthetics Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Volatile Inhalational Anesthetics Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Volatile Inhalational Anesthetics Revenue Market Share Forecast by Application (2027-2032)
